Drug General Information (ID: DDINLSOD8H)
  Drug Name Atazanavir Drug Info Magnesium hydroxide Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Anti-Hiv Agents Antacids/Laxatives
  Structure

 Mechanism of Atazanavir-Magnesium hydroxide Interaction (Severity Level: Moderate)
     Altered gastric pH Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Atazanavir Magnesium hydroxide
      Mechanism Gastric pH sensitive Gastric alkalinizer
      Key Mechanism Factor 1
Factor Name Gastric pH
Factor Description The normal pH range of gastric acid is between 1.5 and 3.5 and is highly acidic, consisting mainly of hydrochloric acid. Changes in the pH of the stomach can alter the absorption of drugs.
      Mechanism Description
  • Decreased absorption of Atazanavir due to altered gastric pH caused by Magnesium hydroxide 

Recommended Action
      Management Atazanavir should be administered 2 hours before or 1 hour after antacids or other oral agents with acid-neutralizing effects.

References
1 Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
2 Ray JE, Marriott D, Bloch MT, McLachlan AJ "Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic." Br J Clin Pharmacol 60 (2005): 291-9. [PMID: 16120068]
3 Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]